Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSeoul National University Hospital

About this trial

This multicenter prospective study aims to evaluate the correlation between quantitative ultrasound fat fraction (USFF) and MRI-PDFF (Proton Density Fat Fraction) for liver fat quantification in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). The study will compare the diagnostic accuracy of quantitative ultrasound imaging against MRI-PDFF as the reference standard.

Eligibility criteria

Qualifiers

Patients with clinically suspected MASLD based on abnormal ultrasound or liver function tests requiring liver ultrasound or MRI examination

BMI ≥25 kg/m² or waist circumference >90 cm (male) or >80 cm (female), suggesting high likelihood of fatty liver disease

Living liver transplant donors requiring preoperative liver ultrasound or MRI examination

Age ≥18 years

Disqualifiers

History of esophageal varices, ascites, hepatic encephalopathy, or acute biliary obstruction

History of liver cancer diagnosis or treatment

History of liver surgery

Pregnancy

Trial design

Treatments tested in this trial

  • Quantitative ultrasound (DeepUSFF)

Treatment groups

62 Participants
are divided into 1 treatment group

Sponsors and collaborators

Seoul National University Hospital

Lead sponsor

Northeastern Ohio Radiology Research and Education Fund

Collaborator